To evaluate therapeutic approaches for pulmonary artery pseudoaneurysms (PAPs) of various etiologies and types and their outcomes, highlighting the significance of tailored management strategies.
Key Findings:
PAPs are associated with a prevalence of 5-11% in patients with embolization of bronchial and non-bronchial systemic collateral arteries.
Hemoptysis severity varies; unruptured PAPs may not cause symptoms, while ruptured PAPs can lead to life-threatening bleeding.
Endovascular embolization is crucial for hemostasis, but PAPs may not always be visualized on pulmonary arteriography, impacting treatment decisions.
Interpretation:
Individualized treatment plans are essential for managing PAPs, considering the diverse etiologies and clinical presentations, which can significantly affect patient outcomes.
Limitations:
Retrospective design may introduce selection bias.
Limited sample size of 29 PAPs may affect generalizability, and potential biases in data collection should be acknowledged.
Conclusion:
Effective management of PAPs requires a tailored approach, emphasizing the importance of accurate diagnosis and appropriate therapeutic strategies to improve patient outcomes.
